What is Celcuity's professional service fees payable?

Celcuity (CELC) reported professional service fees payable of $2.27M in Q1 2026.

What does professional service fees payable mean?

This represents the current liability for unpaid invoices related to third-party professional services such as legal, accounting, consulting, or clinical research organization fees. It reflects the short-term financial obligations incurred for specialized expertise necessary to support ongoing business operations and clinical development activities.

Celcuity CELC Professional Service Fees Payable

Professional Service Fees Payable at other companies

BridgeBio PharmaBBIO

——

Other financials

Income statement

See full

Operating income-$50.5M-39.8%

Net income-$52.8M-42.8%

EPS (diluted)-$0.97-12.8%

Balance sheet

See full

Cash & equivalents$145.2M+781%

Total debt$137.9M+30.7%

Total equity$53.5M-38.2%

Total assets$410.2M+88.0%

Cash flow

See full

Operating cash flow-$55.1M-53.6%

CapEx$249.0K+315%

Free cash flow-$55.3M-54.0%

Valuation

See full

Market cap$4.28B+1,370%

Enterprise value$4.27B+1,086%

Returns & leverage

See full

Return on equity-275.2%-990pp

Debt / equity2.6×+1.4×

Current ratio12.3×+5.7×

Where this comes from

Reported directly by Celcuity in its filing.

Tagged under the XBRL concept us-gaap:AccruedProfessionalFeesCurrent.

The official record: Celcuity’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celcuity's professional service fees payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Celcuity's professional service fees payable?: Celcuity (CELC) reported professional service fees payable of $2.27M in Q1 2026.
What does professional service fees payable mean?: This represents the current liability for unpaid invoices related to third-party professional services such as legal, accounting, consulting, or clinical research organization fees. It reflects the short-term financial obligations incurred for specialized expertise necessary to support ongoing business operations and clinical development activities.